Proteomics in Rare Disease Research Studies using Illumina Protein Prep

In this presentation, you will learn how Illumina Protein Prep (IPP) is being used by Prof. Matt Brown (Genomics England) for research studies in rare disease. Nithya Subramanian (Illumina R&D) presents an introduction to IPP, a sensitive and precise NGS-based solution for proteomics using a >9000-protein panel (available as early access) targeting human proteins across a diverse set of 200+ pathophysiological processes, including cancer, inflammation, immunology, and cardiometabolic function. 

Speakers:

Proteomics and Rare Diseases

Prof. Matt Brown
Chief Scientific Officer, Genomics England, UK

Expanded content and improved performance with Illumina Protein Prep 

Nithya Subramanian
Staff Scientist, Illumina